Tirzepatide is a novel medication that is showing promise in the treatment of type 2 diabetes and as an aid for weight loss
Activin receptor type IIB (ActRIIB) was identified as a key receptor involved in binding ligands such as myostatin and related growth factors
We would like to emphasize that Ozempic is not a weight loss medication, but Ozempic (Semaglutide GLP-1) can also be prescribed for weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension
Infectious causes must also be excluded
Long-Term Therapy The decision to continue, reduce, or stop semaglutide should be guided by four factors: your weight-regain rate during any previous treatment breaks, your genetic predisposition (revealed through peptide pathway testing), the lifestyle changes you've successfully implemented, and your metabolic health markers
If you and your provider determine that oral tirzepatide or a dual-compound option like GLP-Squared better suits your needs, those options are available at their own consistent monthly rates